As SFK can act on several pathways, we chose to analyze pathways that are abnormally activated in leukemia cells and involved in cell motility, migration and chemotaxis, and that is described as in CXCL12/CXCR4 signaling (Zhou et al., 2015). Here, CXCL12 is linked to leukemia.